Caption Management’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-25,400
Closed -$461K 1498
2025
Q1
$461K Sell
25,400
-347,600
-93% -$7.77M ﹤0.01% 1120
2024
Q4
$9.43M Buy
373,000
+23,000
+7% +$625K 0.09% 210
2024
Q3
$11.9M Buy
+350,000
New +$13.3M 0.19% 129
2024
Q2
Sell
-80,000
Closed -$3.36M 1199
2024
Q1
$3.36M Sell
80,000
-35,000
-30% -$1.44M 0.05% 400
2023
Q4
$4.56M Sell
115,000
-85,000
-43% -$2.5M 0.06% 368
2023
Q3
$5.5M Buy
+200,000
New +$6.27M 0.08% 291
2023
Q2
Sell
-109,400
Closed -$3.94M 1141
2023
Q1
$3.94M Sell
109,400
-87,500
-44% -$3.78M 0.08% 283
2022
Q4
$8.78M Hold
196,900
0.14% 182
2022
Q3
$5.54M Sell
196,900
-823,600
-81% -$25.2M 0.08% 310
2022
Q2
$27.5M Buy
1,020,500
+515,300
+102% +$15M 0.38% 46
2022
Q1
$17.2M Buy
505,200
+1,000
+0.2% +$32K 0.21% 106
2021
Q4
$19.5M Buy
504,200
+344,200
+215% +$15M 0.22% 102
2021
Q3
$8.64M Buy
+160,000
New +$7.51M 0.1% 266
2021
Q1
Sell
-100,400
Closed -$1.76M 1083
2020
Q4
$1.76M Buy
+100,400
New +$1.81M 0.04% 473

Other funds holding CLDX